Where Wegovy comes from — and why its origins matter for UK patients

You've seen the name everywhere, but where does Wegovy actually begin?

The story starts in an unlikely place. In the 1990s, researchers studying the Gila monster (a large lizard native to the American Southwest) discovered that its saliva contained a compound that mimicked a gut hormone called GLP-1. That hormone helps regulate appetite and blood sugar. Scientists at Novo Nordisk built on this research to develop semaglutide: a synthetic molecule designed to act like GLP-1 in the human body, but with a much longer half-life so it only needs to be taken once a week.

A common misconception is that Wegovy is some kind of lizard extract. It isn't. The Gila monster provided a biological clue; the medicine itself is produced in laboratory conditions using recombinant DNA technology, where modified yeast cells manufacture the semaglutide molecule. You can read more about what semaglutide actually is and how it works on our semaglutide overview page.

Novo Nordisk, headquartered in Bagsværd, Denmark, has been making insulin and related hormonal medicines since the early twentieth century. Wegovy sits within a long lineage of their diabetes and metabolic-health research. The NHS medicines page for semaglutide gives a patient-level summary of what the medicine does and its safety profile.

How Wegovy's manufacturing translates into what you actually receive

Novo Nordisk manufactures Wegovy at facilities in Denmark and the United States. For the UK market, finished product enters through the licensed UK pharmaceutical supply chain, the regulated network that runs from manufacturer through wholesale dealer to GPhC-registered pharmacy. That supply chain matters because it's the only route that guarantees the product hasn't been tampered with, stored incorrectly, or swapped out entirely.

Wegovy arrives as a pre-filled pen, refrigerated at 2–8°C throughout the journey. Each pen contains a fixed dose, from the 0.25mg starting dose through to the 2.4mg standard maintenance dose, and now the higher 7.2mg pen approved by the MHRA in April 2026. If you're curious about where Wegovy is produced and which facilities are involved, that detail helps explain why the supply chain is so tightly controlled. The manufacturing detail behind each pen involves precision that off-market sellers simply cannot replicate or guarantee.

This is worth dwelling on. The MHRA has documented large seizures of fake weight-loss pens sold online, some containing insulin instead of semaglutide, a potentially life-threatening substitution. Buying Wegovy from a seller who cannot show a GPhC-registered pharmacy behind it is a genuine risk, not a theoretical one. You can verify any online pharmacy on the GPhC register.

Wegovy's regulatory journey to the UK and what that means for you

Novo Nordisk sought and received a UK marketing authorisation from the MHRA for Wegovy as a weight management medicine, separate from Ozempic, which is the same semaglutide molecule but licensed specifically for type 2 diabetes. The MHRA's approval process required the company to demonstrate both safety and efficacy through clinical trial data, including the STEP 1 trial published in the New England Journal of Medicine, which showed around 15% average body-weight reduction over 68 weeks at the 2.4mg maintenance dose.

NICE subsequently assessed Wegovy under technology appraisal TA875 and recommended it for NHS use within specialist weight management services, subject to specific criteria around BMI and weight-related conditions. Most people currently access it privately because NHS waiting lists are long and eligibility thresholds are strict.

For a broader look at what results people see on semaglutide, our Wegovy weight-loss outcomes page covers the trial evidence in plain terms. And if you're thinking about whether it might suit your situation, the route via your GP is one option worth understanding alongside private routes.

Getting genuine Wegovy through a legitimate UK pharmacy

Because Wegovy is a prescription-only medicine, the legal route starts with a clinical assessment. At nume, our GPhC-registered pharmacy sources Wegovy exclusively through authorised UK supply channels. Every consultation is reviewed by a named GPhC-registered Independent Prescriber on the same day, a real clinician reads your answers, not automated software making a binary pass/fail call. If treatment is appropriate, it's dispatched the same day (orders before 12pm, Monday to Friday), with free next-working-day tracked delivery by DPD, in plain packaging.

The full picture of how Wegovy works as a treatment (eligibility, what to expect, how the dose is titrated) is worth reading before you decide. And if you'd like to explore your options across treatments, our weight loss treatment overview covers both Wegovy and Mounjaro side by side.

Worth checking: wherever you're considering getting Wegovy, confirm the pharmacy is GPhC-registered before you hand over any details or payment. That one step filters out the vast majority of unsafe sellers.